Literature DB >> 25675861

An observational study of buprenorphine treatment of the prescription opioid dependent pain patient.

Jon Streltzer1, Raymond Davidson, Deborah Goebert.   

Abstract

BACKGROUND AND OBJECTIVES: In some countries, particularly the United States and Canada, there has been a growing problem of opioid dependence associated with the treatment of chronic pain. Controversy exists regarding the efficacy and safety of opioid therapy, particularly in high doses for extended periods of time. This study reports on the outcome of chronic pain patients treated with buprenorphine in an outpatient psychiatric consultation clinic.
METHODS: Forty three consecutive outpatient clinic chronic pain patients with a DSM-IV diagnosis of opioid dependence and treated with buprenorphine during a 3-year period were monitored for follow-up periods of up to 5 years. All subjects were dependent on drugs prescribed for pain and were divided into two groups: those who had a history of abuse of alcohol or drugs and those who did not Historical, physical, demographic, and outcome data were collected.
RESULTS: The majority of patients were male, not working, and between the ages of 45-60. Follow-up revealed that treatment with buprenorphine was effective. Most patients had improved pain with treatment of the opioid dependence. There were no differences between those with or without a history of substance abuse. DISCUSSION AND
CONCLUSIONS: Patients often improved with much less preoccupation with pain, expressing great satisfaction with buprenorphine treatment. SCIENTIFIC SIGNIFICANCE: Buprenorphine is an effective tool when treating the opioid-dependent chronic pain patient. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25675861     DOI: 10.1111/ajad.12198

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  7 in total

Review 1.  Managing Pain in the Setting of Opioid Use Disorder.

Authors:  Barbara St Marie; Kathleen Broglio
Journal:  Pain Manag Nurs       Date:  2019-10-21       Impact factor: 1.929

2.  Experience of the use of Ketamine to manage opioid withdrawal in an addicted woman: a case report.

Authors:  Laurence Lalanne; Chloe Nicot; Jean-Philippe Lang; Gilles Bertschy; Eric Salvat
Journal:  BMC Psychiatry       Date:  2016-11-10       Impact factor: 3.630

Review 3.  Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.

Authors:  Lynn Webster; Jeffrey Gudin; Robert B Raffa; Jay Kuchera; Richard Rauck; Jeffrey Fudin; Jeremy Adler; Theresa Mallick-Searle
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

4.  Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review.

Authors:  Victoria D Powell; Jack M Rosenberg; Avani Yaganti; Claire Garpestad; Pooja Lagisetty; Carol Shannon; Maria J Silveira
Journal:  JAMA Netw Open       Date:  2021-09-01

5.  Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.

Authors:  Nicholas Avery; Amy G McNeilage; Fiona Stanaway; Claire E Ashton-James; Fiona M Blyth; Rebecca Martin; Ali Gholamrezaei; Paul Glare
Journal:  BMJ       Date:  2022-04-04

Review 6.  A review of trial and real-world data applying elements of a realist approach to identify behavioural mechanisms supporting practitioners to taper opioids.

Authors:  Debi Bhattacharya; Hattie Whiteside; Emma Tang; Kumud Kantilal; Yoon Loke; Bethany Atkins; Caroline Hill
Journal:  Br J Clin Pharmacol       Date:  2022-05-13       Impact factor: 3.716

Review 7.  Benefit-Risk Analysis of Buprenorphine for Pain Management.

Authors:  Martin Hale; Mark Garofoli; Robert B Raffa
Journal:  J Pain Res       Date:  2021-05-24       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.